GIOSTAR CEO and Co-Founder Deven Patel spoke on the most downloaded episode of the “Exploring Leadership” podcast, hosted by military veteran Spence Taylor
Tag: dr anand srivastava
GIOSTAR has continuously set the bar for innovation in cancer research. The firm was recently recognized with a prestigious award, given to only 9 other researchers.
Looking to educate yourself about Fluid Flow Treatment? The amniotic fluid allograft being offered by GIOSTAR is just the latest example of our commitment to innovation in healthcare.
Chronic liver disorders (CLDs) affect roughly 844 million people worldwide, and result in the deaths of about two million people each year. GIOSTAR recently conducted research pointing to the potential benefit of stem cell therapy in addressing this epidemic.
Stem cell therapy has applications that extend beyond traditional disorders (i.e., orthopedic injuries), including skin care. In this blog post, we review the potential benefits of stem cells on wrinkles, acne, psoriasis, and other conditions, and clear up common misconceptions.
Scientific Review: Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients
GIOSTAR leaders recently wrote on the potential benefits of stem cells in combating COVID-19. Published in Stem Cell Reviews and Reports, the review was written by Drs. Anand Srivastava, Prabhat Soni, Diana Esquivel, Rangnath Mishra, Rajasekar Seetharaman, and Anjum Mahmood
Learn more about multiple sclerosis, and how stem cell therapy may provide symptomatic relief for patients suffering from this neurodegenerative disease.
GIOSTAR Chairman and Co-Founder Dr. Anand Srivastava recently spoke with Healthcare Weekly about stem cells, COVID-19, and numerous other topics.
GIOSTAR continues exploring new strategies for managing the world’s most debilitating diseases. Most recently, Dr. Anand Srivastava conducted research on the use of an Ayurvedic medicinal product to address diabetes.